DICE Therapeutics, Inc.
DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE, is designed to discover selective oral small molecules to modulat…
Biotechnology
US, South San Francisco [HQ]
Strategy & Leadership
Mergers & Acquisitions Beta
M&A Details · Industry · Urgent
M&A Deals · Breakdown
DICE Therapeutics, Inc. has no acquisition track records yet.
M&A Deals · History
DICE Therapeutics, Inc. has no acquisition track records yet.
M&A Deals · Within Industry
No current deals within Biotechnology Industry.
M&A Deals · Latest
Act, dont react; Track the most urgent M&A deals across all industries
Details
Details
Details
?
Equity
Agg. Maximum Price
$4,221.65
?
Details
Details
United Bankshares, Inc.
Equity
Agg. Maximum Price
$206,633,909.86
?
Details
Details
Details
Icahn Enterprises L.P.
Debt
Agg. Maximum Price
$700,000,000.00
?
Details
Details
Corebridge Financial, Inc.
Debt
Agg. Maximum Price
$500,000,000.00